Review



pr1  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    OriGene pr1
    Pr1, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/bio_rxiv__64898__2026__05__07__723586-99-16-15?v=OriGene
    Average 95 stars, based on 50 article reviews
    pr1 - by Bioz Stars, 2026-08
    95/100 stars

    Images



    Similar Products

    pr1  (OriGene)
    95
    OriGene pr1
    Pr1, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/bio_rxiv__64898__2026__05__07__723586-99-16-15?v=OriGene
    Average 95 stars, based on 1 article reviews
    pr1 - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    OriGene tgccagtcagaagaacgacc
    Tgccagtcagaagaacgacc, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/bio_rxiv__2025__08__28__672891-224-23-35?v=OriGene
    Average 95 stars, based on 1 article reviews
    tgccagtcagaagaacgacc - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    OriGene gfp fragment
    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of <t>BMDMs</t> <t>(tdTOMATO+;</t> red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from <t>MC38-OVA-GFP,</t> β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.
    Gfp Fragment, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/pm40489329-530-11-17?v=OriGene
    Average 95 stars, based on 1 article reviews
    gfp fragment - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    93
    OriGene crispra
    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of <t>BMDMs</t> <t>(tdTOMATO+;</t> red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from <t>MC38-OVA-GFP,</t> β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.
    Crispra, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/pm39889695-793-4-14?v=OriGene
    Average 93 stars, based on 1 article reviews
    crispra - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    OriGene crispri
    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of <t>BMDMs</t> <t>(tdTOMATO+;</t> red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from <t>MC38-OVA-GFP,</t> β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.
    Crispri, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/pm39889695-793-9-14?v=OriGene
    Average 93 stars, based on 1 article reviews
    crispri - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    OriGene crispri vectors
    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of <t>BMDMs</t> <t>(tdTOMATO+;</t> red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from <t>MC38-OVA-GFP,</t> β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.
    Crispri Vectors, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/pm39889695-790-13-16?v=OriGene
    Average 93 stars, based on 1 article reviews
    crispri vectors - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    95
    OriGene grnas
    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of <t>BMDMs</t> <t>(tdTOMATO+;</t> red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from <t>MC38-OVA-GFP,</t> β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.
    Grnas, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/pm40069152-452-3-12?v=OriGene
    Average 95 stars, based on 1 article reviews
    grnas - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    OriGene pcas guide ef1a gfp vector
    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of <t>BMDMs</t> <t>(tdTOMATO+;</t> red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from <t>MC38-OVA-GFP,</t> β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.
    Pcas Guide Ef1a Gfp Vector, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/pm39934299-66-33-35?v=OriGene
    Average 95 stars, based on 1 article reviews
    pcas guide ef1a gfp vector - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    OriGene sequence 3
    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of <t>BMDMs</t> <t>(tdTOMATO+;</t> red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from <t>MC38-OVA-GFP,</t> β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.
    Sequence 3, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcas+guide+gfp/bio_rxiv__2025__01__08__632037-205-5-12?v=OriGene
    Average 95 stars, based on 1 article reviews
    sequence 3 - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    Image Search Results


    Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of BMDMs (tdTOMATO+; red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from MC38-OVA-GFP, β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.

    Journal: Cell reports

    Article Title: Distinct TAM subset with cross-dressing capability determines the bifurcation of tumor immunity.

    doi: 10.1016/j.celrep.2025.115800

    Figure Lengend Snippet: Figure 3. Acquisition of tumor antigens by TAMs via trogocytosis (A) Trogocytosis activity. BMDMs were co-cultured with CellMask-labeled MC38 cells for 1 h, and CellMask + BMDMs were analyzed using flow cytometry (mean ± SEM, n = 4). (B) Time-lapse imaging of BMDMs (tdTOMATO+; red) co-cultured with CellMask-labeled MC38 cells (green) during trogocytosis. (C) Comparison of trogocytic activity between tumor cells and macrophages (mean ± SEM, n = 3–6). (D and E) Phagocytosis vs. trogocytosis: CFSE-labeled CT26 cells (BALB/c) (live or UV irradiated) were co-cultured with B6-derived BMDMs for 8 h. Phagocytic (CFSE + ) and trogocytic (Kd + ) BMDMs were analyzed using flow cytometry. Representative (D) and summary (E) data are shown (mean ± SEM, n = 6). (F) Representative images of H2-Kb/SIINFEKL in TAMs from MC38-OVA-GFP, β2MKO MC38-OVA-GFP, or MC38-GFP stained with GFP (green), F4/80 (magenta), CD206 (cyan), and H2-Kb/SIINFEKL (red). White arrows indicate CD206 + F4/80 + H2-Kb/SIINFEKL + cells. Scale bar: 50 μm.

    Article Snippet: An all-in-one CRISPR/Cas9 vector with tdTomato was created by replacing the GFP fragment of the pCas-Guide-EF1a-GFP vector (Origene, Rockville, MD, USA) with a tdTomato fragment amplified via PCR, using the BmgBI and ClaI sites.

    Techniques: Activity Assay, Cell Culture, Labeling, Flow Cytometry, Imaging, Comparison, Irradiation, Derivative Assay, Staining